Blood test guides anal cancer treatment: less side effects, better survival?
Disease control
Not yet recruiting
This study tests a personalized approach for anal cancer. Instead of giving everyone the same dose of chemoradiation, doctors will use a blood test (ctDNA) to see how the tumor is responding. People whose cancer responds well get a lower dose to reduce side effects; those who don…
Phase: PHASE2 • Sponsor: Jennifer Dorth • Aim: Disease control
Last updated May 15, 2026 11:53 UTC